CSIR Conclave Showcases Herbal Medicines Revolutionizing Global Healthcare
CSIR conclave showcases traditional medicine innovations worldwide.
The CSIR Startup Conclave in Lucknow has ignited a powerful fusion of ancient Indian wisdom and cutting-edge science, propelling traditional medicines into the global spotlight as affordable, effective solutions for modern health challenges. Held over two days, the event brought together researchers from premier institutions, innovative startups, and key policymakers to showcase how herbal formulations are evolving from lab experiments to market-ready products, positioning India as a frontrunner in the burgeoning herbal healthcare industry.
At the heart of the conclave was the spotlight on four CSIR labs in Lucknow: the National Botanical Research Institute (NBRI), Central Institute of Medicinal and Aromatic Plants (CIMAP), Indian Institute of Toxicology Research (IITR), and Central Drug Research Institute (CDRI). These institutions have collectively pioneered 13 groundbreaking herbal drugs targeting chronic and lifestyle diseases that plague millions worldwide. Among the highlights was the anti-diabetes medication BGR-34, a joint creation of NBRI and CIMAP, which harnesses the power of six potent herbs—Daruharidra, Giloy, Vijaysar, Gudmar, Manjistha, and Methi—to regulate blood sugar levels effectively.
BGR-34, already a trusted name in diabetes management, is now being hailed for its potential in achieving long-term diabetes reversal, aligning with the global shift toward curative rather than just palliative care. Dr. Sanchit Sharma, Executive Director of AIMIL Pharmaceuticals—the company commercializing the drug—enthused, "The worldwide narrative is evolving from mere diabetes control to full reversal. BGR-34 embodies the perfect synergy of Ayurveda and modern science, laying the groundwork for a diabetes-free future."
Also Read: Lucknow Illegal Firecracker Factory Explosion Claims Two Lives
Other innovations on display included paclitaxel, extracted from the Arjuna tree bark to combat blood cancer, and picroliv, a formulation aiding in the treatment of fatty liver and hepatic degeneration. These drugs exemplify how traditional knowledge, backed by rigorous scientific validation, can address pressing health issues with fewer side effects and greater accessibility compared to synthetic alternatives.
Union Science and Technology Minister Dr. Jitendra Singh, who visited the conclave, praised the "lab to people" innovation model, urging startups to capitalize on government-backed technologies. "With rising global demand for natural remedies, India's herbal sector has immense potential in both domestic and international markets," he stated, emphasizing the need for scalable commercialization.
Uttar Pradesh Chief Minister Yogi Adityanath echoed these sentiments during his tour of the exhibition, calling on researchers to fast-track the rollout of these herbal solutions. "Uttar Pradesh stands ready to support this herbal revolution, blending our rich heritage with innovation for global impact," he said.
Industry experts view the conclave as a vital catalyst, bridging the gap between research and entrepreneurship. As Dr. Sharma aptly summarized, "This isn't just about one drug—it's about crafting a sustainable healthcare ecosystem rooted in India's traditions, fueled by science, and poised to compete on the world stage." With events like this, India is not only revitalizing its ancient medicinal legacy but also exporting wellness to the world, potentially transforming global healthcare dynamics.
